A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies
Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled ‘somes’ or nanoparticles), are gaining increasing interest in drug solubilisation and bio-imaging, but they often exhibit poor hemocompatibility and induce cytotoxicity. This limits their appli...
Saved in:
Published in: | Journal of controlled release Vol. 239; pp. 1 - 9 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
10-10-2016
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled ‘somes’ or nanoparticles), are gaining increasing interest in drug solubilisation and bio-imaging, but they often exhibit poor hemocompatibility and induce cytotoxicity. This limits their applications in intravenous drug delivery and targeting. Using a binary mixture of citrem and soy phosphatidylcholine (SPC) at different weight ratios, we describe a library of colloidally stable aqueous and hemocompatible nanodispersions of diverse nanoarchitectures (internal self-assembled nanostructures). This engineered library is structurally stable in human plasma as well as being hemocompatible (non-hemolytic, and poor activator of the complement system). By varying citrem to lipid weight ratio, the nanodispersion susceptibility to macrophage uptake could also be modulated. Finally, the formation of nanodispersions comprising internally V2 (inverse bicontinuous cubic) and H2 (inverse hexagonal) nanoarchitectures was achieved without the use of an organic solvent, a secondary emulsifier, or high-energy input. The tunable binary citrem/SPC nanoplatform holds promise for future development of hemocompatible and immune-safe nanopharmaceuticals.
[Display omitted] |
---|---|
AbstractList | Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled 'somes' or nanoparticles), are gaining increasing interest in drug solubilisation and bio-imaging, but they often exhibit poor hemocompatibility and induce cytotoxicity. This limits their applications in intravenous drug delivery and targeting. Using a binary mixture of citrem and soy phosphatidylcholine (SPC) at different weight ratios, we describe a library of colloidally stable aqueous and hemocompatible nanodispersions of diverse nanoarchitectures (internal self-assembled nanostructures). This engineered library is structurally stable in human plasma as well as being hemocompatible (non-hemolytic, and poor activator of the complement system). By varying citrem to lipid weight ratio, the nanodispersion susceptibility to macrophage uptake could also be modulated. Finally, the formation of nanodispersions comprising internally V2 (inverse bicontinuous cubic) and H2 (inverse hexagonal) nanoarchitectures was achieved without the use of an organic solvent, a secondary emulsifier, or high-energy input. The tunable binary citrem/SPC nanoplatform holds promise for future development of hemocompatible and immune-safe nanopharmaceuticals. Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled ‘somes’ or nanoparticles), are gaining increasing interest in drug solubilisation and bio-imaging, but they often exhibit poor hemocompatibility and induce cytotoxicity. This limits their applications in intravenous drug delivery and targeting. Using a binary mixture of citrem and soy phosphatidylcholine (SPC) at different weight ratios, we describe a library of colloidally stable aqueous and hemocompatible nanodispersions of diverse nanoarchitectures (internal self-assembled nanostructures). This engineered library is structurally stable in human plasma as well as being hemocompatible (non-hemolytic, and poor activator of the complement system). By varying citrem to lipid weight ratio, the nanodispersion susceptibility to macrophage uptake could also be modulated. Finally, the formation of nanodispersions comprising internally V2 (inverse bicontinuous cubic) and H2 (inverse hexagonal) nanoarchitectures was achieved without the use of an organic solvent, a secondary emulsifier, or high-energy input. The tunable binary citrem/SPC nanoplatform holds promise for future development of hemocompatible and immune-safe nanopharmaceuticals. [Display omitted] |
Author | Azmi, Intan D.M. Kazem, Ali I. Moghimi, Seyed M. Wibroe, Peter P. Yaghmur, Anan Wu, Lin-Ping Amenitsch, Heinz |
Author_xml | – sequence: 1 givenname: Intan D.M. surname: Azmi fullname: Azmi, Intan D.M. organization: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark – sequence: 2 givenname: Peter P. surname: Wibroe fullname: Wibroe, Peter P. organization: Nanomedicine Laboratory, Centre for Pharmaceutical Nanotechnology and Nanotoxicology, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark – sequence: 3 givenname: Lin-Ping surname: Wu fullname: Wu, Lin-Ping organization: Nanomedicine Laboratory, Centre for Pharmaceutical Nanotechnology and Nanotoxicology, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark – sequence: 4 givenname: Ali I. surname: Kazem fullname: Kazem, Ali I. organization: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark – sequence: 5 givenname: Heinz surname: Amenitsch fullname: Amenitsch, Heinz organization: Elettra-Sincrotrone Trieste, Strada Statale 14, 34149 Basovizza, Trieste, Italy – sequence: 6 givenname: Seyed M. surname: Moghimi fullname: Moghimi, Seyed M. email: moein.moghimi@gmail.com organization: Nanomedicine Laboratory, Centre for Pharmaceutical Nanotechnology and Nanotoxicology, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark – sequence: 7 givenname: Anan surname: Yaghmur fullname: Yaghmur, Anan email: anan.yaghmur@sund.ku.dk organization: Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen Ø, Denmark |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27524284$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkMtOAyEUhompsRd9BA0vwAhzKTMr0zTekiZudE24nFEahqkwbdKlby5Na7cuTsiB_-c_55uike89IHTLaMYom9-vs7XufQCX5anNaJ1Rxi7QhNW8IGXTVCM0SQ81KeZVM0bTGNeU0qoo-RUa57zKy7wuJ-hngeMQtnrYBuncHhu7gxABO6uCDHvctzjKFojaEwPRfnqs7RCgI5uvPqZydmMNdrID52TA0hucBiXnC2e_t0mgwz4OKcB6wF76nsgYoVPOQrxGl610EW5O5wx9PD2-L1_I6u35dblYEZ02GEiu8rKZM5nXrdKlMZWmivMGeCklaF1UnJU1MK3ampnGGDC8UqoF2swNb3NezFB1_FeHPsYArdgE26UdBaPigFSsxQmpOCAVtBYJafLdHX2brerAnF1_DJPg4SiANP3OQhBRW_AajA2gB2F6-0_EL_m5kTo |
CitedBy_id | crossref_primary_10_1039_D3TB01110K crossref_primary_10_1016_j_cis_2017_04_006 crossref_primary_10_1039_D2NA00530A crossref_primary_10_3390_nano11061510 crossref_primary_10_3390_pharmaceutics14010068 crossref_primary_10_1016_j_ijpharm_2022_122440 crossref_primary_10_1016_j_apsb_2021_02_013 crossref_primary_10_1002_ange_202304977 crossref_primary_10_1016_j_smim_2017_08_013 crossref_primary_10_1039_C8CP04256J crossref_primary_10_1016_j_cocis_2023_101728 crossref_primary_10_1124_jpet_119_258012 crossref_primary_10_1002_adtp_202300161 crossref_primary_10_1016_j_addr_2020_04_012 crossref_primary_10_1021_acs_jpclett_6b02468 crossref_primary_10_1016_j_ijbiomac_2017_11_064 crossref_primary_10_1039_C8BM01196F crossref_primary_10_3390_polym11091400 crossref_primary_10_1016_j_drudis_2019_05_004 crossref_primary_10_3390_molecules29051172 crossref_primary_10_3390_molecules27144602 crossref_primary_10_1016_j_envint_2023_108305 crossref_primary_10_29328_journal_hjb_1001007 crossref_primary_10_1016_j_ijpharm_2018_08_003 crossref_primary_10_1107_S1600576716014199 crossref_primary_10_1021_acs_langmuir_8b01149 crossref_primary_10_1021_acs_langmuir_6b04045 crossref_primary_10_1021_acsomega_7b01935 crossref_primary_10_1002_adfm_201904007 crossref_primary_10_1021_acsami_2c14375 crossref_primary_10_1002_anie_202304977 crossref_primary_10_1016_j_jconrel_2022_05_036 crossref_primary_10_1016_j_colsurfb_2021_111753 crossref_primary_10_1016_j_jcis_2018_03_063 crossref_primary_10_3390_nano10091649 crossref_primary_10_1039_C9CP02393C crossref_primary_10_1039_C9CP01878F crossref_primary_10_1080_17425247_2020_1819979 crossref_primary_10_1021_acs_langmuir_7b03078 crossref_primary_10_3390_ph15040429 crossref_primary_10_3389_fbioe_2019_00384 crossref_primary_10_3389_frsfm_2023_1109508 crossref_primary_10_1021_acs_molpharmaceut_3c00333 crossref_primary_10_1016_j_colsurfb_2017_02_031 crossref_primary_10_1016_j_jcis_2020_07_038 crossref_primary_10_1016_j_jcis_2024_04_186 crossref_primary_10_1016_j_mtla_2020_100705 crossref_primary_10_1021_acsabm_1c00932 crossref_primary_10_1016_j_jconrel_2016_09_005 crossref_primary_10_3390_molecules25030638 crossref_primary_10_4155_tde_2018_0062 crossref_primary_10_1021_acsnano_3c09231 crossref_primary_10_1016_j_jcis_2020_08_085 crossref_primary_10_1016_j_chemphyslip_2024_105377 crossref_primary_10_1016_j_jcis_2020_08_084 crossref_primary_10_1016_j_chemphyslip_2018_09_003 crossref_primary_10_1016_j_colsurfa_2021_126697 crossref_primary_10_1016_j_jcis_2017_07_083 crossref_primary_10_1166_jnn_2021_19064 crossref_primary_10_35118_apjmbb_2023_031_2_02 crossref_primary_10_1016_j_actbio_2018_12_009 crossref_primary_10_1016_j_foodchem_2023_137446 crossref_primary_10_2174_1573413719666230303102952 crossref_primary_10_3390_molecules25010016 crossref_primary_10_1039_C7AN00860K crossref_primary_10_1016_j_jcis_2021_07_149 crossref_primary_10_1016_j_jconrel_2022_09_039 |
Cites_doi | 10.1021/nl050678i 10.1016/S0006-3495(97)78336-X 10.1016/j.addr.2011.06.002 10.1039/C3TX50075F 10.1021/acs.langmuir.5b00830 10.1016/S1359-0294(00)00040-6 10.3109/08982109909044491 10.1021/am501489e 10.1126/science.7233185 10.1021/la0499416 10.1021/la0482711 10.1529/biophysj.105.061432 10.1007/s11095-010-0130-x 10.1016/j.ijpharm.2010.03.016 10.1016/j.cis.2008.07.007 10.1016/j.nano.2015.08.003 10.1021/ja043331a 10.1016/0262-8856(90)90059-E 10.1021/la053464p 10.1146/annurev-pharmtox-010611-134623 10.1021/la010161w 10.1039/c3ra44583f 10.1021/jp984551b 10.1007/BF00213556 10.1039/C0CP01029D 10.1016/j.jconrel.2015.02.034 10.1021/la501411w 10.1021/la035313x 10.1371/journal.pone.0002072 10.1016/j.ejps.2011.09.016 10.1016/j.cis.2014.03.005 10.1021/la504115a 10.1016/j.jconrel.2013.05.030 10.1016/j.ijpharm.2013.03.016 10.1016/j.molimm.2008.08.276 10.1371/journal.pone.0003747 10.4155/tde.15.81 10.1016/j.jconrel.2015.11.021 10.1021/bp0498544 10.1088/0953-8984/18/28/S01 10.1007/s002329900535 10.1039/C5RA02604K 10.1002/adhm.201300533 10.1016/j.ejpb.2016.05.001 10.1021/bi960866a 10.1146/annurev.immunol.23.021704.115816 10.1023/A:1011986613392 10.1021/la960318y 10.1039/C4FO00045E |
ContentType | Journal Article |
Copyright | 2016 Elsevier B.V. Copyright © 2016 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2016 Elsevier B.V. – notice: Copyright © 2016 Elsevier B.V. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1016/j.jconrel.2016.08.011 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-4995 |
EndPage | 9 |
ExternalDocumentID | 10_1016_j_jconrel_2016_08_011 27524284 S0168365916305132 |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AABXZ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AEZYN AFKWA AFRZQ AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HMT IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SDF SDG SDP SES SPC SPCBC SSM SSP SSZ T5K TEORI ~G- AAHBH AAXKI AKRWK CGR CUY CVF ECM EIF NPM .GJ 29K 3O- AAQXK AAYOK AAYXX ABXDB ACNNM ADMUD AFJKZ AHHHB ASPBG AVWKF AZFZN CITATION D-I FEDTE FGOYB G-2 HVGLF HZ~ R2- SEW SPT WUQ |
ID | FETCH-LOGICAL-c365t-2b24961a28fbc4dd5c0b779e74aaecc357148e1cbf81d9dded75bbfe096d7f273 |
ISSN | 0168-3659 |
IngestDate | Thu Sep 26 15:44:02 EDT 2024 Wed Oct 16 00:58:06 EDT 2024 Fri Feb 23 02:33:27 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Immune-safe nanopharmaceuticals Lamellar and non-lamellar liquid crystalline phases Complement system Cubosomes Hexosomes Macrophage |
Language | English |
License | Copyright © 2016 Elsevier B.V. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c365t-2b24961a28fbc4dd5c0b779e74aaecc357148e1cbf81d9dded75bbfe096d7f273 |
PMID | 27524284 |
PageCount | 9 |
ParticipantIDs | crossref_primary_10_1016_j_jconrel_2016_08_011 pubmed_primary_27524284 elsevier_sciencedirect_doi_10_1016_j_jconrel_2016_08_011 |
PublicationCentury | 2000 |
PublicationDate | 2016-10-10 |
PublicationDateYYYYMMDD | 2016-10-10 |
PublicationDate_xml | – month: 10 year: 2016 text: 2016-10-10 day: 10 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of controlled release |
PublicationTitleAlternate | J Control Release |
PublicationYear | 2016 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Klösgen, Helfrich (bb0140) 1993; 22 Yaghmur, Laggner, Sartori, Rappolt (bb0215) 2008; 3 Hui, Stewart, Boni, Yeagle (bb0225) 1981; 212 Wibroe, Mat Azmi, Nilsson, Yaghmur, Moghimi (bb0040) 2015; 11 Spicer, Hayden, Lynch, Ofori-Boateng, Burns (bb0090) 2001; 17 Campo, Yaghmur, Sagalowicz, Leser, Watzke, Glatter (bb0155) 2004; 20 Mouritsen, Jørgensen (bb0235) 1998; 15 Shearman, Ces, Templer, Seddon (bb0200) 2006; 18 Yaghmur, Glatter (bb0125) 2009; 147-148 Yaghmur, Campo, Sagalowicz, Leser, Glatter (bb0160) 2005; 21 Barauskas, Johnsson, Tiberg (bb0005) 2005; 5 Yuen, Princen, Illingworth, Kittler (bb0185) 1990; 8 Neto, Aloisi, Baglioni, Larsson (bb0100) 1999; 103 Fricker, Kromp, Wendel, Blume, Zirkel, Rebmann, Setzer, Quinkert, Martin, Müller-Goymann (bb0070) 2010; 27 Cha, Guo, Zhu (bb0205) 2006; 90 Rosa, Rosa Infante, Miguel, Lindman (bb0110) 2006; 22 Gustafsson, Ljusberg-Wahren, Almgren, Larsson (bb0190) 1996; 12 Hønger, Jørgensen, Biltonen, Mouritsen (bb0240) 1996; 35 Amara, Patin, Giuffrida, Wooster, Thakkar, Bénarouche, Poncin, Robert, Point, Molinari, Gaussier, Diomande, Destaillats, Cruz-Hernandez, Carrière (bb0095) 2014; 5 Bode, Kuntsche, Funari, Bunjes (bb0230) 2013; 448 Hedegaard, Nilsson, Laurinmäki, Butcher, Urtti, Yaghmur (bb0150) 2013; 3 Azmi, Moghimi, Yaghmur (bb0015) 2015; 6 Hinton, Grusche, Acharya, Shukla, Bansal, Waddington, Monaghan, Muir (bb0035) 2014; 3 Weiszhár, Czúcz, Révész, Rosivall, Szebeni, Rozsnyay (bb0055) 2012; 45 Martiel, Sagalowicz, Mezzenga (bb0060) 2014; 209 Johnsson, Barauskas, Tiberg (bb0115) 2005; 127 Wu, Wang, Parhamifar (bb0135) 2014; 3 Barauskas, Cervin, Jankunec, Špandyreva, Ribokaitė, Tiberg, Johnsson (bb0075) 2010; 391 Azhari, Strauss, Hook, Boyd, Rizwan (bb0010) 2016; 104 Yaghmur, Laggner, Almgren, Rappolt (bb0145) 2008; 3 Martiel, Handschin, Fong, Sagalowicz, Mezzenga (bb0065) 2015; 31 Wibroe, Ahmadvand, Oghabian, Yaghmur, Moghimi (bb0130) 2016; 221 Hamad, Hunter, Szebeni, Moghimi (bb0050) 2008; 46 Lasic (bb0195) 1999; 9 Tran, Mulet, Hawley, Hinton, Mudie, Muir, Giakoumatos, Waddington, Kirby, Drummond (bb0030) 2015; 5 Abraham, Hato, Hirai (bb0020) 2008; 21 Pantazatos, MacDonald (bb0210) 1999; 170 Mat Azmi, Wu, Wibroe, Nilsson, Østergaard, Stürup, Gammelgaard, Urtti, Moghimi, Yaghmur (bb0025) 2015; 31 Kamo, Nakano, Leesajakul, Sugita, Matsuoka, Handa (bb0085) 2003; 19 Martiel, Baumann, Vallooran, Bergfreund, Sagalowicz, Mezzenga (bb0105) 2015; 204 Taylor, Martinez-Pomares, Stacey, Lin, Brown, Gordon (bb0255) 2005; 23 Moghimi, Andersen, Ahmadvand, Wibroe, Andresen, Hunter (bb0245) 2011; 63 Wadsäter, Barauskas, Nylander, Tiberg (bb0080) 2014; 6 Ljusberg-Wahern, Nyberg, Larsson (bb0120) 1996; 14 Siegel, Epand (bb0220) 1997; 73 Moghimi, Hunter, Andresen (bb0250) 2012; 52 Hamad, Hunter, Moghimi (bb0045) 2013; 170 Nilsson, Østergaard, Larsen, Larsen, Urtti, Yaghmur (bb0170) 2014; 30 Larsson (bb0165) 2000; 5 Angelov, Angelova, Mutafchieva, Lesieur, Vainio, Garamus, Jensen, Pedersen (bb0175) 2011; 13 Wright (bb0180) 2012; vol. 906 Wu (10.1016/j.jconrel.2016.08.011_bb0135) 2014; 3 Lasic (10.1016/j.jconrel.2016.08.011_bb0195) 1999; 9 Wadsäter (10.1016/j.jconrel.2016.08.011_bb0080) 2014; 6 Yaghmur (10.1016/j.jconrel.2016.08.011_bb0160) 2005; 21 Taylor (10.1016/j.jconrel.2016.08.011_bb0255) 2005; 23 Hamad (10.1016/j.jconrel.2016.08.011_bb0045) 2013; 170 Amara (10.1016/j.jconrel.2016.08.011_bb0095) 2014; 5 Martiel (10.1016/j.jconrel.2016.08.011_bb0060) 2014; 209 Nilsson (10.1016/j.jconrel.2016.08.011_bb0170) 2014; 30 Yaghmur (10.1016/j.jconrel.2016.08.011_bb0125) 2009; 147-148 Shearman (10.1016/j.jconrel.2016.08.011_bb0200) 2006; 18 Yaghmur (10.1016/j.jconrel.2016.08.011_bb0215) 2008; 3 Klösgen (10.1016/j.jconrel.2016.08.011_bb0140) 1993; 22 Azmi (10.1016/j.jconrel.2016.08.011_bb0015) 2015; 6 Mouritsen (10.1016/j.jconrel.2016.08.011_bb0235) 1998; 15 Yaghmur (10.1016/j.jconrel.2016.08.011_bb0145) 2008; 3 Yuen (10.1016/j.jconrel.2016.08.011_bb0185) 1990; 8 Hinton (10.1016/j.jconrel.2016.08.011_bb0035) 2014; 3 Wibroe (10.1016/j.jconrel.2016.08.011_bb0130) 2016; 221 Gustafsson (10.1016/j.jconrel.2016.08.011_bb0190) 1996; 12 Weiszhár (10.1016/j.jconrel.2016.08.011_bb0055) 2012; 45 Campo (10.1016/j.jconrel.2016.08.011_bb0155) 2004; 20 Moghimi (10.1016/j.jconrel.2016.08.011_bb0245) 2011; 63 Spicer (10.1016/j.jconrel.2016.08.011_bb0090) 2001; 17 Mat Azmi (10.1016/j.jconrel.2016.08.011_bb0025) 2015; 31 Barauskas (10.1016/j.jconrel.2016.08.011_bb0075) 2010; 391 Abraham (10.1016/j.jconrel.2016.08.011_bb0020) 2008; 21 Larsson (10.1016/j.jconrel.2016.08.011_bb0165) 2000; 5 Cha (10.1016/j.jconrel.2016.08.011_bb0205) 2006; 90 Barauskas (10.1016/j.jconrel.2016.08.011_bb0005) 2005; 5 Azhari (10.1016/j.jconrel.2016.08.011_bb0010) 2016; 104 Rosa (10.1016/j.jconrel.2016.08.011_bb0110) 2006; 22 Hui (10.1016/j.jconrel.2016.08.011_bb0225) 1981; 212 Siegel (10.1016/j.jconrel.2016.08.011_bb0220) 1997; 73 Fricker (10.1016/j.jconrel.2016.08.011_bb0070) 2010; 27 Martiel (10.1016/j.jconrel.2016.08.011_bb0105) 2015; 204 Moghimi (10.1016/j.jconrel.2016.08.011_bb0250) 2012; 52 Ljusberg-Wahern (10.1016/j.jconrel.2016.08.011_bb0120) 1996; 14 Hønger (10.1016/j.jconrel.2016.08.011_bb0240) 1996; 35 Wright (10.1016/j.jconrel.2016.08.011_bb0180) 2012; vol. 906 Pantazatos (10.1016/j.jconrel.2016.08.011_bb0210) 1999; 170 Martiel (10.1016/j.jconrel.2016.08.011_bb0065) 2015; 31 Tran (10.1016/j.jconrel.2016.08.011_bb0030) 2015; 5 Hamad (10.1016/j.jconrel.2016.08.011_bb0050) 2008; 46 Bode (10.1016/j.jconrel.2016.08.011_bb0230) 2013; 448 Neto (10.1016/j.jconrel.2016.08.011_bb0100) 1999; 103 Hedegaard (10.1016/j.jconrel.2016.08.011_bb0150) 2013; 3 Angelov (10.1016/j.jconrel.2016.08.011_bb0175) 2011; 13 Wibroe (10.1016/j.jconrel.2016.08.011_bb0040) 2015; 11 Johnsson (10.1016/j.jconrel.2016.08.011_bb0115) 2005; 127 Kamo (10.1016/j.jconrel.2016.08.011_bb0085) 2003; 19 |
References_xml | – volume: 3 start-page: 817 year: 2014 end-page: 824 ident: bb0135 article-title: Poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) nanoparticles with polyethylenimine coat as simple, safe, and versatile vehicles for cell targeting: population characteristics, cell uptake, and intracellular trafficking publication-title: Adv. Healthcare Mater. contributor: fullname: Parhamifar – volume: 15 start-page: 1507 year: 1998 end-page: 1519 ident: bb0235 article-title: A new look at lipid-membrane structure in relation to drug research publication-title: Pharm. Res. contributor: fullname: Jørgensen – volume: 104 start-page: 148 year: 2016 end-page: 155 ident: bb0010 article-title: Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood–brain barrier publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Rizwan – volume: 22 start-page: 329 year: 1993 end-page: 340 ident: bb0140 article-title: Special features of phosphatidylcholine vesicles as seen in cryo-transmission electron microscopy publication-title: Eur. Biophys. J. contributor: fullname: Helfrich – volume: 18 start-page: S1105 year: 2006 end-page: S1124 ident: bb0200 article-title: Inverse lyotropic phases of lipids and membrane curvature publication-title: J. Phys. Condens. Matter contributor: fullname: Seddon – volume: 13 start-page: 3073 year: 2011 end-page: 3081 ident: bb0175 article-title: SAXS investigation of a cubic to a sponge (L publication-title: Phys. Chem. Chem. Phys. contributor: fullname: Pedersen – volume: 3 start-page: e2072 year: 2008 ident: bb0215 article-title: Calcium triggered L publication-title: PLoS One contributor: fullname: Rappolt – volume: 221 start-page: 1 year: 2016 end-page: 8 ident: bb0130 article-title: An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, Doxorubicin, and SinaDoxosome publication-title: J. Control. Release contributor: fullname: Moghimi – volume: 391 start-page: 284 year: 2010 end-page: 291 ident: bb0075 article-title: Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes publication-title: Int. J. Pharm. contributor: fullname: Johnsson – volume: 6 start-page: 7063 year: 2014 end-page: 7069 ident: bb0080 article-title: Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase publication-title: ACS Appl. Mater. Interfaces contributor: fullname: Tiberg – volume: 5 start-page: 26785 year: 2015 end-page: 26795 ident: bb0030 article-title: Nanostructure and cytotoxicity of self-assembled monoolein–capric acid lyotropic liquid crystalline nanoparticles publication-title: RSC Adv. contributor: fullname: Drummond – volume: 17 start-page: 5748 year: 2001 end-page: 5756 ident: bb0090 article-title: Novel process for producing cubic liquid crystalline nanoparticles (Cubosomes) publication-title: Langmuir contributor: fullname: Burns – volume: 20 start-page: 5254 year: 2004 end-page: 5261 ident: bb0155 article-title: Reversible phase transitions in emulsified nanostructured lipid systems publication-title: Langmuir contributor: fullname: Glatter – volume: 30 start-page: 6398 year: 2014 end-page: 6407 ident: bb0170 article-title: Characterization of oil-free and oil-loaded liquid-crystalline particles stabilized by negatively charged stabilizer citrem publication-title: Langmuir contributor: fullname: Yaghmur – volume: 6 start-page: 1347 year: 2015 end-page: 1364 ident: bb0015 article-title: Cubosomes and hexosomes as versatile platforms for drug delivery publication-title: Ther. Deliv. contributor: fullname: Yaghmur – volume: 46 start-page: 225 year: 2008 end-page: 232 ident: bb0050 article-title: Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process publication-title: Mol. Immunol. contributor: fullname: Moghimi – volume: 21 start-page: 255 year: 2008 end-page: 262 ident: bb0020 article-title: Polymer-dispersed bicontinuous cubic glycolipid nanoparticles publication-title: Biotechnol. Prog. contributor: fullname: Hirai – volume: 14 start-page: 40 year: 1996 end-page: 43 ident: bb0120 article-title: Dispersion of the cubic liquid crystalline phase - Structure preparation and functionality aspects publication-title: Chim. Oggi contributor: fullname: Larsson – volume: 23 start-page: 901 year: 2005 end-page: 944 ident: bb0255 article-title: Macrophage receptors and immune recognition publication-title: Annu. Rev. Immunol. contributor: fullname: Gordon – volume: 147-148 start-page: 333 year: 2009 end-page: 342 ident: bb0125 article-title: Characterization and potential applications of nanostructured aqueous dispersions publication-title: Adv. Colloid Interf. Sci. contributor: fullname: Glatter – volume: 5 start-page: 1409 year: 2014 end-page: 1421 ident: bb0095 article-title: In vitro digestion of citric acid esters of mono- and diglycerides (citrem) and citrem-containing infant formula/emulsions publication-title: Food Funct. contributor: fullname: Carrière – volume: 73 start-page: 3089 year: 1997 end-page: 3111 ident: bb0220 article-title: The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: Implications for membrane fusion mechanisms publication-title: Biophys. J. contributor: fullname: Epand – volume: 8 start-page: 71 year: 1990 end-page: 77 ident: bb0185 article-title: Comparative study of Hough Transform methods for circle finding publication-title: Image Vis. Comput. contributor: fullname: Kittler – volume: 90 start-page: 1270 year: 2006 end-page: 1274 ident: bb0205 article-title: Formation of supported phospholipid bilayers on molecular surfaces: role of surface charge density and electrostatic interaction publication-title: Biophys. J. contributor: fullname: Zhu – volume: 3 start-page: 11 year: 2014 end-page: 22 ident: bb0035 article-title: Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells publication-title: Toxicol. Res. contributor: fullname: Muir – volume: 31 start-page: 96 year: 2015 end-page: 104 ident: bb0065 article-title: Oil transfer converts phosphatidylcholine vesicles into nonlamellar lyotropic liquid crystalline particles publication-title: Langmuir contributor: fullname: Mezzenga – volume: 448 start-page: 87 year: 2013 end-page: 95 ident: bb0230 article-title: Interaction of dispersed cubic phases with blood components publication-title: Int. J. Pharm. contributor: fullname: Bunjes – volume: 212 start-page: 921 year: 1981 end-page: 923 ident: bb0225 article-title: Membrane fusion through point defects in bilayers publication-title: Science contributor: fullname: Yeagle – volume: 170 start-page: 167 year: 2013 end-page: 174 ident: bb0045 article-title: Complement monitoring of pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100 publication-title: J. Control. Release contributor: fullname: Moghimi – volume: 103 start-page: 3896 year: 1999 end-page: 3899 ident: bb0100 article-title: Imaging soft matter with the atomic force microscope: cubosomes and hexosomes publication-title: J. Phys. Chem. B contributor: fullname: Larsson – volume: 11 start-page: 1909 year: 2015 end-page: 1914 ident: bb0040 article-title: Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: towards development of safe tunable intravenous lipid nanocarriers publication-title: Nanomedicine contributor: fullname: Moghimi – volume: 5 start-page: 1615 year: 2005 end-page: 1619 ident: bb0005 article-title: Self-assembled lipid superstructures: beyond vesicles and liposomes publication-title: Nano Lett. contributor: fullname: Tiberg – volume: 3 start-page: e3747 year: 2008 ident: bb0145 article-title: Self-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition publication-title: PLoS One contributor: fullname: Rappolt – volume: 27 start-page: 1469 year: 2010 end-page: 1486 ident: bb0070 article-title: Phospholipids and lipid-based formulations in oral drug delivery publication-title: Pharm. Res. contributor: fullname: Müller-Goymann – volume: 63 start-page: 1000 year: 2011 end-page: 1007 ident: bb0245 article-title: Material properties in complement activation publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Hunter – volume: 31 start-page: 5042 year: 2015 end-page: 5049 ident: bb0025 article-title: Modulatory effect of human plasma on the internal nanostructure and size characteristics of liquid-crystalline nanocarriers publication-title: Langmuir contributor: fullname: Yaghmur – volume: 22 start-page: 5588 year: 2006 end-page: 5596 ident: bb0110 article-title: Spontaneous formation of vesicles and dispersed cubic and hexagonal particles in amino acid-based catanionic surfactant systems publication-title: Langmuir contributor: fullname: Lindman – volume: 21 start-page: 569 year: 2005 end-page: 577 ident: bb0160 article-title: Emulsified microemulsions and oil-containing liquid crystalline phases publication-title: Langmuir contributor: fullname: Glatter – volume: 170 start-page: 27 year: 1999 end-page: 38 ident: bb0210 article-title: Directly observed membrane fusion between oppositely charged phospholipid bilayers publication-title: J. Membr. Biol. contributor: fullname: MacDonald – volume: 204 start-page: 78 year: 2015 end-page: 84 ident: bb0105 article-title: Oil and drug control the release rate from lyotropic liquid crystals publication-title: J. Control. Release contributor: fullname: Mezzenga – volume: vol. 906 start-page: 511 year: 2012 end-page: 524 ident: bb0180 article-title: Nanoparticle tracking analysis for the multi-parameter characterization and counting of nanoparticle suspensions publication-title: Nanoparticles in Biology and Medicine: Methods and Protocols contributor: fullname: Wright – volume: 52 start-page: 481 year: 2012 end-page: 503 ident: bb0250 article-title: Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective publication-title: Annu. Rev. Pharmacol. Toxicol. contributor: fullname: Andresen – volume: 5 start-page: 64 year: 2000 end-page: 69 ident: bb0165 article-title: Aqueous dispersions of cubic lipid–water phases publication-title: Curr. Opin. Colloid Interface Sci. contributor: fullname: Larsson – volume: 127 start-page: 1076 year: 2005 end-page: 1077 ident: bb0115 article-title: Cubic phases and cubic phase dispersions in a phospholipid-based system publication-title: J. Am. Chem. Soc. contributor: fullname: Tiberg – volume: 19 start-page: 9191 year: 2003 end-page: 9195 ident: bb0085 article-title: Nonlamellar liquid crystalline phases and their particle formation in the egg yolk phosphatidylcholine/diolein system publication-title: Langmuir contributor: fullname: Handa – volume: 12 start-page: 4611 year: 1996 end-page: 4613 ident: bb0190 article-title: Cubic lipid-water phase dispersed into submicron particles publication-title: Langmuir contributor: fullname: Larsson – volume: 35 start-page: 9003 year: 1996 end-page: 9006 ident: bb0240 article-title: Systematic relationship between phospholipase A2 activity and dynamic lipid bilayer microheterogeneity publication-title: Biochemistry contributor: fullname: Mouritsen – volume: 45 start-page: 492 year: 2012 end-page: 498 ident: bb0055 article-title: Complement activation by polyethoxylated pharmaceutical surfactants: cremophor-EL, Tween-80 and Tween-20 publication-title: Eur. J. Pharm. Sci. contributor: fullname: Rozsnyay – volume: 209 start-page: 127 year: 2014 end-page: 143 ident: bb0060 article-title: Phospholipid-based nonlamellar mesophases for delivery systems: bridging the gap between empirical and rational design publication-title: Adv. Colloid Interf. Sci. contributor: fullname: Mezzenga – volume: 9 start-page: 43 year: 1999 end-page: 52 ident: bb0195 article-title: Spontaneous vesiculation and spontaneous liposomes publication-title: J. Liposome Res. contributor: fullname: Lasic – volume: 3 start-page: 24576 year: 2013 end-page: 24585 ident: bb0150 article-title: Nanostructured aqueous dispersions of citrem interacting with lipids and PEGylated lipids publication-title: RSC Adv. contributor: fullname: Yaghmur – volume: 5 start-page: 1615 year: 2005 ident: 10.1016/j.jconrel.2016.08.011_bb0005 article-title: Self-assembled lipid superstructures: beyond vesicles and liposomes publication-title: Nano Lett. doi: 10.1021/nl050678i contributor: fullname: Barauskas – volume: 73 start-page: 3089 year: 1997 ident: 10.1016/j.jconrel.2016.08.011_bb0220 article-title: The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: Implications for membrane fusion mechanisms publication-title: Biophys. J. doi: 10.1016/S0006-3495(97)78336-X contributor: fullname: Siegel – volume: 63 start-page: 1000 year: 2011 ident: 10.1016/j.jconrel.2016.08.011_bb0245 article-title: Material properties in complement activation publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2011.06.002 contributor: fullname: Moghimi – volume: 3 start-page: 11 year: 2014 ident: 10.1016/j.jconrel.2016.08.011_bb0035 article-title: Bicontinuous cubic phase nanoparticle lipid chemistry affects toxicity in cultured cells publication-title: Toxicol. Res. doi: 10.1039/C3TX50075F contributor: fullname: Hinton – volume: 31 start-page: 5042 year: 2015 ident: 10.1016/j.jconrel.2016.08.011_bb0025 article-title: Modulatory effect of human plasma on the internal nanostructure and size characteristics of liquid-crystalline nanocarriers publication-title: Langmuir doi: 10.1021/acs.langmuir.5b00830 contributor: fullname: Mat Azmi – volume: 5 start-page: 64 year: 2000 ident: 10.1016/j.jconrel.2016.08.011_bb0165 article-title: Aqueous dispersions of cubic lipid–water phases publication-title: Curr. Opin. Colloid Interface Sci. doi: 10.1016/S1359-0294(00)00040-6 contributor: fullname: Larsson – volume: 9 start-page: 43 year: 1999 ident: 10.1016/j.jconrel.2016.08.011_bb0195 article-title: Spontaneous vesiculation and spontaneous liposomes publication-title: J. Liposome Res. doi: 10.3109/08982109909044491 contributor: fullname: Lasic – volume: 6 start-page: 7063 year: 2014 ident: 10.1016/j.jconrel.2016.08.011_bb0080 article-title: Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase publication-title: ACS Appl. Mater. Interfaces doi: 10.1021/am501489e contributor: fullname: Wadsäter – volume: 212 start-page: 921 year: 1981 ident: 10.1016/j.jconrel.2016.08.011_bb0225 article-title: Membrane fusion through point defects in bilayers publication-title: Science doi: 10.1126/science.7233185 contributor: fullname: Hui – volume: 20 start-page: 5254 year: 2004 ident: 10.1016/j.jconrel.2016.08.011_bb0155 article-title: Reversible phase transitions in emulsified nanostructured lipid systems publication-title: Langmuir doi: 10.1021/la0499416 contributor: fullname: Campo – volume: 14 start-page: 40 year: 1996 ident: 10.1016/j.jconrel.2016.08.011_bb0120 article-title: Dispersion of the cubic liquid crystalline phase - Structure preparation and functionality aspects publication-title: Chim. Oggi contributor: fullname: Ljusberg-Wahern – volume: 21 start-page: 569 year: 2005 ident: 10.1016/j.jconrel.2016.08.011_bb0160 article-title: Emulsified microemulsions and oil-containing liquid crystalline phases publication-title: Langmuir doi: 10.1021/la0482711 contributor: fullname: Yaghmur – volume: 90 start-page: 1270 year: 2006 ident: 10.1016/j.jconrel.2016.08.011_bb0205 article-title: Formation of supported phospholipid bilayers on molecular surfaces: role of surface charge density and electrostatic interaction publication-title: Biophys. J. doi: 10.1529/biophysj.105.061432 contributor: fullname: Cha – volume: 27 start-page: 1469 year: 2010 ident: 10.1016/j.jconrel.2016.08.011_bb0070 article-title: Phospholipids and lipid-based formulations in oral drug delivery publication-title: Pharm. Res. doi: 10.1007/s11095-010-0130-x contributor: fullname: Fricker – volume: 391 start-page: 284 year: 2010 ident: 10.1016/j.jconrel.2016.08.011_bb0075 article-title: Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2010.03.016 contributor: fullname: Barauskas – volume: 147-148 start-page: 333 year: 2009 ident: 10.1016/j.jconrel.2016.08.011_bb0125 article-title: Characterization and potential applications of nanostructured aqueous dispersions publication-title: Adv. Colloid Interf. Sci. doi: 10.1016/j.cis.2008.07.007 contributor: fullname: Yaghmur – volume: 11 start-page: 1909 year: 2015 ident: 10.1016/j.jconrel.2016.08.011_bb0040 article-title: Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: towards development of safe tunable intravenous lipid nanocarriers publication-title: Nanomedicine doi: 10.1016/j.nano.2015.08.003 contributor: fullname: Wibroe – volume: 127 start-page: 1076 year: 2005 ident: 10.1016/j.jconrel.2016.08.011_bb0115 article-title: Cubic phases and cubic phase dispersions in a phospholipid-based system publication-title: J. Am. Chem. Soc. doi: 10.1021/ja043331a contributor: fullname: Johnsson – volume: 8 start-page: 71 year: 1990 ident: 10.1016/j.jconrel.2016.08.011_bb0185 article-title: Comparative study of Hough Transform methods for circle finding publication-title: Image Vis. Comput. doi: 10.1016/0262-8856(90)90059-E contributor: fullname: Yuen – volume: 22 start-page: 5588 year: 2006 ident: 10.1016/j.jconrel.2016.08.011_bb0110 article-title: Spontaneous formation of vesicles and dispersed cubic and hexagonal particles in amino acid-based catanionic surfactant systems publication-title: Langmuir doi: 10.1021/la053464p contributor: fullname: Rosa – volume: 52 start-page: 481 year: 2012 ident: 10.1016/j.jconrel.2016.08.011_bb0250 article-title: Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev-pharmtox-010611-134623 contributor: fullname: Moghimi – volume: 17 start-page: 5748 year: 2001 ident: 10.1016/j.jconrel.2016.08.011_bb0090 article-title: Novel process for producing cubic liquid crystalline nanoparticles (Cubosomes) publication-title: Langmuir doi: 10.1021/la010161w contributor: fullname: Spicer – volume: 3 start-page: 24576 year: 2013 ident: 10.1016/j.jconrel.2016.08.011_bb0150 article-title: Nanostructured aqueous dispersions of citrem interacting with lipids and PEGylated lipids publication-title: RSC Adv. doi: 10.1039/c3ra44583f contributor: fullname: Hedegaard – volume: 103 start-page: 3896 year: 1999 ident: 10.1016/j.jconrel.2016.08.011_bb0100 article-title: Imaging soft matter with the atomic force microscope: cubosomes and hexosomes publication-title: J. Phys. Chem. B doi: 10.1021/jp984551b contributor: fullname: Neto – volume: 22 start-page: 329 year: 1993 ident: 10.1016/j.jconrel.2016.08.011_bb0140 article-title: Special features of phosphatidylcholine vesicles as seen in cryo-transmission electron microscopy publication-title: Eur. Biophys. J. doi: 10.1007/BF00213556 contributor: fullname: Klösgen – volume: 13 start-page: 3073 year: 2011 ident: 10.1016/j.jconrel.2016.08.011_bb0175 article-title: SAXS investigation of a cubic to a sponge (L3) phase transition in self-assembled lipid nanocarriers publication-title: Phys. Chem. Chem. Phys. doi: 10.1039/C0CP01029D contributor: fullname: Angelov – volume: 204 start-page: 78 year: 2015 ident: 10.1016/j.jconrel.2016.08.011_bb0105 article-title: Oil and drug control the release rate from lyotropic liquid crystals publication-title: J. Control. Release doi: 10.1016/j.jconrel.2015.02.034 contributor: fullname: Martiel – volume: 30 start-page: 6398 year: 2014 ident: 10.1016/j.jconrel.2016.08.011_bb0170 article-title: Characterization of oil-free and oil-loaded liquid-crystalline particles stabilized by negatively charged stabilizer citrem publication-title: Langmuir doi: 10.1021/la501411w contributor: fullname: Nilsson – volume: 19 start-page: 9191 year: 2003 ident: 10.1016/j.jconrel.2016.08.011_bb0085 article-title: Nonlamellar liquid crystalline phases and their particle formation in the egg yolk phosphatidylcholine/diolein system publication-title: Langmuir doi: 10.1021/la035313x contributor: fullname: Kamo – volume: 3 start-page: e2072 year: 2008 ident: 10.1016/j.jconrel.2016.08.011_bb0215 article-title: Calcium triggered Lα-H2 phase transition monitored by combined rapid mixing and time-resolved synchrotron SAXS publication-title: PLoS One doi: 10.1371/journal.pone.0002072 contributor: fullname: Yaghmur – volume: 45 start-page: 492 year: 2012 ident: 10.1016/j.jconrel.2016.08.011_bb0055 article-title: Complement activation by polyethoxylated pharmaceutical surfactants: cremophor-EL, Tween-80 and Tween-20 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2011.09.016 contributor: fullname: Weiszhár – volume: 209 start-page: 127 year: 2014 ident: 10.1016/j.jconrel.2016.08.011_bb0060 article-title: Phospholipid-based nonlamellar mesophases for delivery systems: bridging the gap between empirical and rational design publication-title: Adv. Colloid Interf. Sci. doi: 10.1016/j.cis.2014.03.005 contributor: fullname: Martiel – volume: 31 start-page: 96 year: 2015 ident: 10.1016/j.jconrel.2016.08.011_bb0065 article-title: Oil transfer converts phosphatidylcholine vesicles into nonlamellar lyotropic liquid crystalline particles publication-title: Langmuir doi: 10.1021/la504115a contributor: fullname: Martiel – volume: 170 start-page: 167 year: 2013 ident: 10.1016/j.jconrel.2016.08.011_bb0045 article-title: Complement monitoring of pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins AI and B-100 publication-title: J. Control. Release doi: 10.1016/j.jconrel.2013.05.030 contributor: fullname: Hamad – volume: 448 start-page: 87 year: 2013 ident: 10.1016/j.jconrel.2016.08.011_bb0230 article-title: Interaction of dispersed cubic phases with blood components publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.03.016 contributor: fullname: Bode – volume: 46 start-page: 225 year: 2008 ident: 10.1016/j.jconrel.2016.08.011_bb0050 article-title: Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2008.08.276 contributor: fullname: Hamad – volume: 3 start-page: e3747 year: 2008 ident: 10.1016/j.jconrel.2016.08.011_bb0145 article-title: Self-assembly in monoelaidin aqueous dispersions: direct vesicles to cubosomes transition publication-title: PLoS One doi: 10.1371/journal.pone.0003747 contributor: fullname: Yaghmur – volume: 6 start-page: 1347 year: 2015 ident: 10.1016/j.jconrel.2016.08.011_bb0015 article-title: Cubosomes and hexosomes as versatile platforms for drug delivery publication-title: Ther. Deliv. doi: 10.4155/tde.15.81 contributor: fullname: Azmi – volume: 221 start-page: 1 year: 2016 ident: 10.1016/j.jconrel.2016.08.011_bb0130 article-title: An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, Doxorubicin, and SinaDoxosome publication-title: J. Control. Release doi: 10.1016/j.jconrel.2015.11.021 contributor: fullname: Wibroe – volume: 21 start-page: 255 year: 2008 ident: 10.1016/j.jconrel.2016.08.011_bb0020 article-title: Polymer-dispersed bicontinuous cubic glycolipid nanoparticles publication-title: Biotechnol. Prog. doi: 10.1021/bp0498544 contributor: fullname: Abraham – volume: 18 start-page: S1105 year: 2006 ident: 10.1016/j.jconrel.2016.08.011_bb0200 article-title: Inverse lyotropic phases of lipids and membrane curvature publication-title: J. Phys. Condens. Matter doi: 10.1088/0953-8984/18/28/S01 contributor: fullname: Shearman – volume: 170 start-page: 27 year: 1999 ident: 10.1016/j.jconrel.2016.08.011_bb0210 article-title: Directly observed membrane fusion between oppositely charged phospholipid bilayers publication-title: J. Membr. Biol. doi: 10.1007/s002329900535 contributor: fullname: Pantazatos – volume: 5 start-page: 26785 year: 2015 ident: 10.1016/j.jconrel.2016.08.011_bb0030 article-title: Nanostructure and cytotoxicity of self-assembled monoolein–capric acid lyotropic liquid crystalline nanoparticles publication-title: RSC Adv. doi: 10.1039/C5RA02604K contributor: fullname: Tran – volume: 3 start-page: 817 year: 2014 ident: 10.1016/j.jconrel.2016.08.011_bb0135 article-title: Poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) nanoparticles with polyethylenimine coat as simple, safe, and versatile vehicles for cell targeting: population characteristics, cell uptake, and intracellular trafficking publication-title: Adv. Healthcare Mater. doi: 10.1002/adhm.201300533 contributor: fullname: Wu – volume: 104 start-page: 148 year: 2016 ident: 10.1016/j.jconrel.2016.08.011_bb0010 article-title: Stabilising cubosomes with Tween 80 as a step towards targeting lipid nanocarriers to the blood–brain barrier publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2016.05.001 contributor: fullname: Azhari – volume: vol. 906 start-page: 511 year: 2012 ident: 10.1016/j.jconrel.2016.08.011_bb0180 article-title: Nanoparticle tracking analysis for the multi-parameter characterization and counting of nanoparticle suspensions contributor: fullname: Wright – volume: 35 start-page: 9003 year: 1996 ident: 10.1016/j.jconrel.2016.08.011_bb0240 article-title: Systematic relationship between phospholipase A2 activity and dynamic lipid bilayer microheterogeneity publication-title: Biochemistry doi: 10.1021/bi960866a contributor: fullname: Hønger – volume: 23 start-page: 901 year: 2005 ident: 10.1016/j.jconrel.2016.08.011_bb0255 article-title: Macrophage receptors and immune recognition publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.23.021704.115816 contributor: fullname: Taylor – volume: 15 start-page: 1507 year: 1998 ident: 10.1016/j.jconrel.2016.08.011_bb0235 article-title: A new look at lipid-membrane structure in relation to drug research publication-title: Pharm. Res. doi: 10.1023/A:1011986613392 contributor: fullname: Mouritsen – volume: 12 start-page: 4611 year: 1996 ident: 10.1016/j.jconrel.2016.08.011_bb0190 article-title: Cubic lipid-water phase dispersed into submicron particles publication-title: Langmuir doi: 10.1021/la960318y contributor: fullname: Gustafsson – volume: 5 start-page: 1409 year: 2014 ident: 10.1016/j.jconrel.2016.08.011_bb0095 article-title: In vitro digestion of citric acid esters of mono- and diglycerides (citrem) and citrem-containing infant formula/emulsions publication-title: Food Funct. doi: 10.1039/C4FO00045E contributor: fullname: Amara |
SSID | ssj0005347 |
Score | 2.5300677 |
Snippet | Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled ‘somes’ or nanoparticles), are gaining increasing... Non-lamellar liquid crystalline aqueous nanodispersions, known also as ISAsomes (internally self-assembled 'somes' or nanoparticles), are gaining increasing... |
SourceID | crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1 |
SubjectTerms | Animals Complement system Cubosomes Drug Carriers - chemistry Drug Design Hexosomes Humans Immune-safe nanopharmaceuticals Lamellar and non-lamellar liquid crystalline phases Liquid Crystals - chemistry Macrophage Mice Nanostructures - chemistry Particle Size Phospholipids - chemistry RAW 264.7 Cells |
Title | A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies |
URI | https://dx.doi.org/10.1016/j.jconrel.2016.08.011 https://www.ncbi.nlm.nih.gov/pubmed/27524284 |
Volume | 239 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Pb5swFLay9rLLtN_rfsmHqRfqrBiD8RGtmdpJmyI1k3pDGBuNiJC0aQ70tv98z9gEukbqNmmHoMhJwOH78t7nl_eeEfrAqKZhkMEiJ5ARYaZMBvy6IEpESjDT3SQz8Y7Tc_7tIj6ZsMlo1G0t2Y_9V6RhDLA2lbN_gfb2pDAAzwFzOALqcPwj3BPPtoQ17TSqxlNt3oX2XLTGaMN1VmgiG6La5A0vL6-v9IKsfizX8KjKVak8oInJirL5lfWyJtuBqrzcwBvyqwZkZdVq1DqrlwQ0uF7IqktJvCt3XU58pVW7T8vgT6HkZlFaUwVC1TsZfx33wSDpUhXbNGJv2r-ycQEFMu18r_Ea2Y1e2LKd0jsbDyMafmRcgcttbcNsd0ptbOQzikkQufbh2lrrmAcElmzh0JxT2xzJGWR_4NnFTpdhoxfz8RzuA3x_k-0XtV1dnRO43Y373MzDTAN0LNizALz_PgUbByZ2PzmbXHzp84sCZmv13bz78rGPOy92jzAaqJ7ZY_TI4YcTy7MnaKTrp-hwavudN0d41pfvrY_wIZ72ndCbZ-hngodkxI6M2JERLwt8m4x4Bxlxxz0MZMRDMmJLRjwgI_6NjM_R98-T2adT4vb8IDncpGtCJWUi8jMaFzJnSoX5seRcaM6yDKxNEHJYv2s_lwUstAT4ZsVDKQsNK3HFC9DiL9AezES_Qjjww5zngkVMURbpQgS60IIeZyCKhWbsAI27G56ubGuXtMt5nKcOodQglJqdWn3_AMUdLKnTp1Z3psCl-z760sK4vRLlIajjmL3-95O-QQ_7n89btAeA6nfowVpt3jsy_gIfusM6 |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+structurally+diverse+library+of+safe-by-design+citrem-phospholipid+lamellar+and+non-lamellar+liquid+crystalline+nano-assemblies&rft.jtitle=Journal+of+controlled+release&rft.au=Azmi%2C+Intan+D.M.&rft.au=Wibroe%2C+Peter+P.&rft.au=Wu%2C+Lin-Ping&rft.au=Kazem%2C+Ali+I.&rft.date=2016-10-10&rft.pub=Elsevier+B.V&rft.issn=0168-3659&rft.eissn=1873-4995&rft.volume=239&rft.spage=1&rft.epage=9&rft_id=info:doi/10.1016%2Fj.jconrel.2016.08.011&rft.externalDocID=S0168365916305132 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0168-3659&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0168-3659&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0168-3659&client=summon |